Reviva Pharmaceuticals Holdings, Inc (RVPH)

Etorro trading 970x250

About Reviva Pharmaceuticals Holdings, Inc

Reviva Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychotic symptoms, dementia or Alzheimer’s disease, parkinson’s disease psychosis, and attention deficit hyperactivity disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California. Address: 19925 Stevens Creek Boulevard, Cupertino, CA, United States, 95014

Reviva Pharmaceuticals Holdings, Inc News and around…

Latest news about Reviva Pharmaceuticals Holdings, Inc (RVPH) common stock and company :

12 Health Care Stocks Moving In Wednesday's Intraday Session
24 Nov, 2021 FinancialContent

Gainers Biofrontera (NASDAQ:BFRI) shares increased by 160.83% to $6.86 during Wednesday's regular session. The company's market cap ...

RVPH: Phase III Initiation Before Year End
16 Nov, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT Third Quarter 2021 Financial and Operational Results On November 15, 2021, Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) announced third quarter 2021 financial and operational results and filed its Form 10-Q with the SEC for the period ending September 30, 2021. Reviva is on the cusp of launching its Phase III

Reviva Pharmaceuticals Holdings, Inc. Reports Third Quarter 2021 Financial Results and Recent Business Highlights
15 Nov, 2021 Yahoo! Finance

- Initiation of a pivotal Phase 3 trial evaluating the efficacy and safety of brilaroxazine for the treatment of schizophrenia expected by year-end - - Additional Phase 3 trial evaluating the long-term safety of brilaroxazine in adult patients with schizophrenia expected to begin by year-end - - $33.5 Million in Cash as of September 30, 2021 - CUPERTINO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage ph

Reviva Pharmaceuticals to Present at the Upcoming Benzinga Healthcare Small Cap Conference
15 Sep, 2021 FinancialContent
Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
02 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Monday's Pre-Market Session
30 Aug, 2021 FinancialContent

Gainers Valneva (NASDAQ:VALN) stock rose 17.45% to $45.22 during Monday's pre-market session. The market value of ...

RVPH: Second Quarter Update
25 Aug, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT Second Quarter 2021 Financial and Operational Results On August 16, 2021, Reviva Pharmaceutical Holdings, Inc. (NASDAQ: RVPH) presented to investors its second quarter 2021 financial and operational results and filed its Form 10-Q with the SEC. Highlights for the quarter ending June 30, 2021 and to date include: ➢ Report of

12 Health Care Stocks Moving In Tuesday's Intraday Session
24 Aug, 2021 FinancialContent

Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As ...

Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2021 Financial Results and Recent Business Highlights
16 Aug, 2021 FinancialContent
Stocks That Hit 52-Week Lows On Tuesday
03 Aug, 2021 FinancialContent

On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands ...

Stocks That Hit 52-Week Lows On Monday
02 Aug, 2021 FinancialContent

Monday morning, 34 companies reached new 52-week lows. Things to Consider: Las Vegas Sands (NYSE:LVS) was ...

12 Health Care Stocks Moving In Monday's After-Market Session
26 Jul, 2021 FinancialContent

Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) stock increased by 25.64% to $3.92 during Monday's after-market session. The company's ...

Reviva Pharma Stock Is Trading Higher After Maxim Initiated With Buy, Target Price Of $10
26 Jul, 2021 FinancialContent

Reviva Pharmaceuticals Holdings Inc(NASDAQ: RVPH) is trading higher with around 60k in session volume. Maximinitiated ...

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021
26 Jul, 2021 FinancialContent

Upgrades Tudor Pickering upgraded the previous rating for Precision Drilling Corp (NYSE:PDS) from Hold to Buy. Precision ...

Reviva Added to Russell Microcap® Index
28 Jun, 2021 FinancialContent
Is Reviva Pharmaceuticals Holdings, Inc. (RVPH) A Good Stock To Buy?
21 Jun, 2021 Yahoo! Finance

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]

12 Health Care Stocks Moving In Friday's Pre-Market Session
04 Jun, 2021 FinancialContent

Gainers Windtree Therapeutics (NASDAQ:WINT) stock moved upwards by 29.79% to $2.57 during Friday's pre-market ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
27 May, 2021 FinancialContent

Gainers Zosano Pharma (NASDAQ:ZSAN) stock moved upwards by 22.59% to $0.91 during Thursday's pre-market session. The ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
27 May, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the day with a look at the biggest pre-market stock movers for Thursday, including winners and losers. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering
27 May, 2021 FinancialContent
Reviva: Developing Next-Generation Antipsychotic Drug
17 May, 2021 FinancialContent

Schizophrenia is the most common psychotic disease with a global prevalence in about 1% of the population, affecting approximately 3.5 ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
27 Apr, 2021 FinancialContent

Gainers Aldeyra Therapeutics (NASDAQ:ALDX) stock moved upwards by 25.29% to $13.92 during Tuesday's pre-market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning
27 Apr, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tuesday's here and InvestorsPlace.com is ready with a look at the biggest pre-market movers winning and losing this morning. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now

58 Biggest Movers From Yesterday
27 Apr, 2021 FinancialContent

Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company ...

RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% on Monday
26 Apr, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in RVPH stock saw some pretty massive gains, as the company announced impressive results for its schizophrenia drug. The post RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% on Monday appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now

Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving Today
26 Apr, 2021 FinancialContent

Voyager Therapeutics, Inc. (NASDAQ: VYGR), uniQure N.V. (NASDAQ: QURE), Axsome Therapeutics, Inc. (NASDAQ: AXSM), Reviva ...

12 Health Care Stocks Moving In Monday's Intraday Session
26 Apr, 2021 FinancialContent

Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva ...

38 Stocks Moving In Monday's Mid-Day Session
26 Apr, 2021 FinancialContent

Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 46.9% to $6.25 after the company announced the full details of ...

Reviva Soars as Schizophrenia Treatment Meets Primary Endpoint
26 Apr, 2021 Yahoo! Finance

Reviva Pharmaceuticals says a Phase 2 clinical trial for its acute schizophrenia treatment meets its primary endpoint.

Reviva Pharma Stock Trading Higher On Detailed Positive Schizophrenia Study Results
26 Apr, 2021 FinancialContent

Reviva Pharmaceuticals Holdings Inc(NASDAQ: RVPH) hasannounced the full detailsof its Phase 2 trial evaluating its ...

Reviva Pharmaceuticals Holdings, Inc (RVPH) is a NASDAQ Common Stock listed in , ,

970x250